Want to learn more about MOMA?
We're excited to share that our CEO, Asit Parikh, M.D., Ph.D., will represent MOMA at two upcoming investor conferences: he will be speaking on a panel at the Guggenheim Global Healthcare Conference 2024 and presenting at the Piper Sandler 36th Annual Healthcare Conference. Learn more: https://lnkd.in/eyPWUq6k
'Tis the season for innovation! ☃️ From welcoming the latest Capital Readiness cohort and unlocking the U.S. healthcare market to celebrating alumni breaking new ground globally, our December newsletter has it covered. Read it here❄️ ➡️ https://lnkd.in/eqxJUGeX
Perseverance and transformation are the themes for 2025 in healthcare. The recent AMGA webinar, 'Thriving in Tomorrow's Healthcare,' offered invaluable insights from Vivek Garg, MD, MBA, Yair Lewis & Dana McCalley, MBA ⭐⭐⭐⭐⭐ Don’t miss the roadmap for value-based success
“2025 is about perseverance. If you've made the commitment to truly change the value equation for the patients you serve, this is a challenging time.” Last week’s webinar with American Medical Group Association (AMGA), Thriving in Tomorrow's Healthcare: A Roadmap for Value-Based Success in 2025, took a deep dive into challenges and opportunities facing healthcare leaders in the coming year. A big thank you to our panelists Dana McCalley, MBA and Dr. Yair Lewis, and especially to Vivek Garg, MD, MBA who joined us on his birthday! To hear their playbook for success in the new year, watch the webinar on-demand here: https://lnkd.in/dq7KQFqG
National Healthcare Business Development Executive I Strategic Business Partner I Connector I Master Networker
Healthcare transaction & deal makers here is an event to place on your radar for next month! King & Spalding! #HealthcareTransaction #HealthcareLaw #BusinessDevelopment #FMV #DealMakers #businessdevelopment
Partner and Chair, Health Care Transactional and Regulatory Practice at King & Spalding
We are excited to sponsor the Inaugural Healthcare Deal Summit held on September 17, 2024, at King & Spalding’s New York office. If you are a client, company or an investor in the healthcare space who would like to attend Healthcare Deal Summit, click the link below. https://shorturl.at/c9y5P
Discover how we enabled a preeminent global healthcare authority in clinical trial design through the development of a custom cloud-based solution, significantly elevating trial efficiency and safety, while concurrently achieving considerable reductions in time and costs. Our collaboration exemplifies Emids’ steadfast dedication, agility and substantial impact to make healthcare better for all. Read the complete case study here- https://lnkd.in/eSTGT7Xg
What a great Value Analysis session at Breakthroughs: A Premier Inc. Conference Experience from 2 Association of Healthcare Value Analysis Professionals (AHVAP) members! Dr, Pat Patton and Joe Bichler. Value Analysis pearls of wisdom from a physician and an IDN Executive Leader. Thank you both!! Our industry is better with both of you working towards the Quadruple Aim!!
💡 Check out the final segment of our 'Making Market Access Real' series focusing on Accelerating Innovation. Where our panel of experts Richard Stubbs, Chair of the National Health Innovation Network, Kate Woolland, Chief Operating Officer, Closed Loop Medicine, Jim McArdle, Strategy Lead, Patient Services, IQVIA and Paul Henderson, Director of Consulting, UK&I Healthcare & Government, IQVIA, dive into the crucial topic of cross-company adoption of innovation. Discover the importance of bringing together different organisations and focusing on pathways that align with your local healthcare system. Watch the video now!
Reimagining Clinical Trials – A thought-provoking panel moderated by the Managing Principal of Axiom Healthcare Strategies, featuring exertise among physicians and industry leaders: Hossein Borghaei, Corey Langer, Shruti Agrawal, Robert LaCaze, Alan Bash, and Nicholas Davies. Explore innovative approaches transforming traditional trial models. To learn more about our work supporting innovation in study designs, reach out to our Chief of Strategy, Anne Cherry, at [email protected] Watch the full panel here: https://lnkd.in/gbS9MWNY #ClinicalTrials #FutureOfClinicalTrials #InnovatingResearch #ClinicalTrialsReimagined #AxiomSummit
Looking forward to participating in this panel discussion on the policy impact on healthcare market access
Join us tomorrow for an extraordinary panel discussion featuring Rich Ramko from EY, Ali Samiian from Stoparkinson Healthcare Systems Inc, Matt Wetzel from Goodwin, and Darya Rose from Gilead Sciences. Together, they'll unravel the intricacies of Policy Impact on Healthcare Market Access. At the CELS Showcase, we're committed to bringing together influential voices, and this session promises to be nothing short of inspiring. Don't miss the opportunity to connect with leaders in the health and innovation sectors. Joanne Fedeyko Hatim Chraibi Richard Ayllon Veronica C. Angele Maki
I’m thrilled to be on a panel at the upcoming Nashville Healthcare Sessions conference! I’ll be joining industry leaders Adam Boehler from Rubicon Founders and Anna Haghgooie from Valtruis. Together, we’ll explore the evolution of healthcare investing and the current landscape after a tumultuous five years. What can you expect? 🤔 🔍 Insights into market maturation and what we’re observing in today’s investment strategies. 💡 Discussion on how these dynamics are influencing capital strategies for companies moving forward. 📈 An overview of the changes operators are making to secure the best deals. 🔮 A look at investor trends for the remainder of the year and what’s on the horizon for 2025. This is a fantastic opportunity to gain valuable insights and network with fellow healthcare enthusiasts and professionals. Don’t miss out on what promises to be a thought-provoking and informative session! #NashvilleHealthcareSessions #HealthcareInvestment #PanelDiscussion #Networking #HealthcareInnovation #InvestSmart #2025Trends
Catch our COO Kate Woolland together with a panel of experts for the final segment of IQVIA UK and Ireland 's “Making Market Access Real” series, focusing on accelerating innovation. This week’s segment transitions from discussing the challenges behind the implementation of innovative solutions in healthcare to the crucial topic of cross-company adoption of innovation. The panel highlights the importance of bringing together different organizations and focusing on pathways, alongside products, to successfully introduce innovations into the NHS, concluding with top tips for innovators. At Closed Loop Medicine, our mission is to provide a pathway for all individuals to access high-quality personalized treatment, by enabling real-time, real-world drug dose optimization of both new and established medicines – offering precision care for all whilst supporting healthcare providers and addressing the current shortfall in scalable personalized healthcare solutions. Listen to the full discussion below 👇 #Healthcare #Innovation #NHS #PrecisionCare
💡 Check out the final segment of our 'Making Market Access Real' series focusing on Accelerating Innovation. Where our panel of experts Richard Stubbs, Chair of the National Health Innovation Network, Kate Woolland, Chief Operating Officer, Closed Loop Medicine, Jim McArdle, Strategy Lead, Patient Services, IQVIA and Paul Henderson, Director of Consulting, UK&I Healthcare & Government, IQVIA, dive into the crucial topic of cross-company adoption of innovation. Discover the importance of bringing together different organisations and focusing on pathways that align with your local healthcare system. Watch the video now!
